Objectives: The aim of this study was to analyse the interplay among plasmid-mediated qnr genes, alone or in combination with multiple chromosomal-mediated fluoroquinolone (FQ) resistance determinants, susceptibility to FQs and bacterial fitness in an isogenic Escherichia coli collection.
Introduction
Antibiotic resistance is currently a significant problem in public healthcare. Fluoroquinolones (FQs) are potent antibacterial drugs that bind to bacterial type II topoisomerases (DNA gyrase and topoisomerase IV) when they are forming a complex with DNA. 1 The bactericidal effect of FQs has recently been linked to the production of reactive oxygen species (ROS), which has been described as a common path for explaining how antibiotics kill bacteria and produce radical-induced mutagenesis. 2, 3 Because FQs have broad-spectrum bactericidal activity, they are used in the treatment of a variety of bacterial infections. As quinolones became more widely used, bacterial resistance to them rapidly emerged and this has continued to increase in both human and veterinary isolates over the past three decades. 4 The rapidity of this increase is somewhat surprising because clinically relevant levels of resistance in Escherichia coli require multiple genetic changes, 5, 6 some of which are associated with modified bacterial fitness. 6, 7 A full understanding of the factors driving this problem would be useful for developing an effective strategy to restrict the increase in resistance.
Quinolone resistance in Gram-negative bacilli (GNB) is due primarily to mutations in chromosomal genes encoding quinolone targets and, to a lesser extent, changes in outer membrane proteins or efflux pumps. 4, 8 Plasmid-mediated resistance determinants have also been reported encoding for different proteins: the Qnr proteins, which belong to the pentapeptide repeat family (PRP), 9 the acetyltransferase AAC(6 ′ )-Ib-cr variant 10 and the QepA and OqxAB active efflux pumps. 11, 12 The prevalence of Enterobacteriaceae with plasmid-mediated quinolone resistance (PMQR) due to qnr genes has been described as increasing worldwide. 4, 9 This rapid spread may come as a surprise since the acquisition of a qnr gene confers only low-level quinolone resistance (LLQR). 5, 13 Qnr proteins bind to DNA gyrase and topoisomerase IV, protecting them from quinolone inhibition. Nonetheless, the native function of Qnr proteins still remains obscure. 4, 14 It is possible that the interaction between Qnr proteins and type II topoisomerases somehow affects both the regular replication of the bacterial chromosome and bacterial fitness. Other antibiotic resistance mechanisms, including chromosomally mediated FQ resistance mutations, have been associated with a fitness cost. 15 There is not always a concordance in the interplay between resistance and fitness, and bacteria are able to reverse the cost induced by acquiring resistance. Also, resistance mechanisms can both enhance fitness and increase resistance. 6, 16 The emergence of resistance may be driven by the Darwinian selection for improved fitness, not just antibiotic use. 15 The effect of such mechanisms on fitness is a key parameter for evaluating the epidemiological implications of a given microorganism, which is dependent on its ability to persist in bacterial populations once selective antibiotic pressure has disappeared. 17 We hypothesize that Qnr proteins have an effect on bacterial fitness, which may have contributed to the emergence of qnr genes.
The aim of this paper was to investigate the interplay between Qnr proteins and chromosomally mediated quinolone resistance mechanisms in terms of quinolone susceptibility and biological cost. To examine this interplay, we constructed a collection of 61 isogenic E. coli strains carrying combinations of four chromosomally mediated quinolone resistance mechanisms and five Qnr proteins belonging to different families. 4 These resistance mechanisms are commonly found in FQ-resistant clinical E. coli. 1, 18 The relationships between the number of resistance mutations and bacterial fitness were complex, and in some cases the addition of a resistance mutation improved bacterial fitness. These findings could have implications for the evolution of FQ resistance in the absence of antibiotic exposure.
Materials and methods

Strains, growth conditions and antimicrobial agents
Wild-type E. coli ATCC 25922 was used as the starting strain for all constructions (Table 1 ). This strain is routinely used in clinical laboratories as a control for antimicrobial susceptibility tests (www.atcc.org). 19 LB, liquid or solid, was routinely used. Mueller -Hinton (MH) broth and M9 minimal medium, containing glucose as the sole carbon source, were used when required for susceptibility assays and growth experiments, respectively. Strains were grown at 378C. Kanamycin (Sigma-Aldrich, Madrid, Spain) was dissolved at 30 mg/mL and then further diluted in selective media for pBK-CMV stability. Chloramphenicol (Sigma-Aldrich) was dissolved at 25 mg/mL and then further diluted in selective media for pACYC184 stability.
The quinolones used were nalidixic acid (Sigma-Aldrich), ciprofloxacin (Sigma-Aldrich), levofloxacin (Sigma-Aldrich), moxifloxacin (SigmaAldrich), norfloxacin (Sigma-Aldrich) and ofloxacin (Sigma-Aldrich). Stock solutions were prepared in accordance with CLSI guidelines (www. clsi.org). 19 
Construction of isogenic strains
gyrA and parC mutants were obtained by gene replacement as previously described [ Table 1 and Table S1 (available as Supplementary data at JAC Online)]. 5, 20 The mutated fragment was inserted into the chromosome by homologous recombination. The cointegrate was resolved by intramolecular recombination of the allele pair. The resolution process was confirmed by PCR.
Disruption of the marR and lacZ genes was carried out using the method, suitably modified, described by Datsenko and Wanner. 21 The Red helper pKOBEG (kindly donated by G. Bou, A Coruñ a, Spain) (Table S1 ) is a low copy number plasmid containing the Red system, which comprises an exonuclease and the b and g functions of phage l. A selectable kanamycin resistance gene from the pKD4 vector was amplified by PCR from genomic DNA using primers with 5
′ extensions with homology to the marR and lacZ genes, listed in Table S1 . The kanamycin resistance gene was then eliminated using the helper plasmid pCP20 encoding the FLP recombinase and subsequently cured.
qnr genes, including the promoter sequences ( 150 bp upstream of the encoding sequence), were amplified using the primers indicated in Table S1 and then cloned into the kanamycin-resistant pBK-CMV vector. The construction was purified and sequenced to verify the inverted orientation with respect to the P lac promoter of these genes. The qnr genes carried on the pBK-CMV cloning vector were transformed by electroporation into E. coli ATCC 25922 and its isogenic mutant strains (Table 1) . qnrA1 was also cloned in the pACYC184 vector for qnr co-expression assays. 22 
MIC determination
MICs were determined in triplicate for each bacterial strain using the broth microdilution method, according to CLSI reference methods. 19 
Mutant prevention concentration (MPC) determination
MPCs were determined, as previously described by Marcusson et al. 23 In summary, for each strain used in the study, 100 mL of an overnight culture was inoculated into 100 mL of MH broth and then incubated at 378C with aeration for 6 h, until an OD 540 of 1.0 was reached (Genesys 20, Termo, Barcelona, Spain), corresponding to 10 9 cells/mL. Next, 10 mL aliquots of culture were centrifuged at 4000 rpm for 20 min. The supernatant was discarded and the pellet containing ≥10 10 cells was resuspended in the remaining liquid and spread onto an MH agar plate containing a specific concentration of quinolone. Each strain was tested against FQs in double dilution at different concentrations (using log 2 dilutions ranging from 0.002 to 128 mg/L). The plates were incubated at 378C for a total of 96 h and examined every 24 h for the appearance of colonies. The MPC was recorded as the lowest quinolone concentration at which no colonies grew on an agar plate at 96 h. The MPC for each strain was determined in at least three independent experiments. The variation between experiments was not more than one log 2 dilution. 
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Mutant selection rate
To evaluate whether strains might become resistant to ciprofloxacin more easily if they possessed LLQR mechanisms, the frequency of mutant selection was determined by plating an overnight culture of viable microorganisms on MH agar plates without and with ciprofloxacin (1 mg/L and 4×MIC). The colony count was determined after 48 h at 378C from three independent assays. The frequency of mutants was expressed as the ratio of the number of resistant mutants recovered to the total viable bacteria obtained from the drug-free MH agar plates. 24 
Growth rate measurements
Bacterial strains were grown in LB and M9 media at 378C and 180 rpm. The maximal growth rate and exponential doubling times were calculated by measuring the increase in OD at 600 nm every 20 min using an Infinite 200Pro multimode microplate reader (Tecan, Mä nnedorf, Switzerland). After overnight culture in LB at 378C, bacterial suspensions were diluted to achieve an OD of 0.1 at 625 nm, and then diluted 100 times in M9 medium and 10 000 times in LB medium. Microplates were inoculated with the obtained suspensions. Each combination of strain and medium was run in 6-fold. Plates were incubated at 378C for 48 h and shaken for 10 s every 10 min. The log 10 of each value of OD was measured. To estimate the doubling time, a slope was calculated between every second consecutive value. After discarding artefacts, the maximal growth rate was calculated. The doubling time was calculated as the log 10 value of 2 divided by the maximal growth rate. 25 Experiments were performed in triplicate.
Growth competition assays
E. coli ATCC 25922 DlacZ was used as the standard reference strain against constructed mutants in the growth competition assays. This strain was also tested against its parent, showing that the DlacZ mutation was neutral. To support the statistical analysis, each competition was tested in at least six independent experiments (Table 1) . To initiate growth competition, each strain was grown in LB at 378C for 12 h, mixed in a 1: 1 ratio, diluted 10
23 -fold into LB broth and then grown for 23 h to complete a growth cycle. Each successive growth cycle was initiated by diluting the mixture 10
23 -fold into LB broth. The number of times each competition experiment (4 cycles, 96 h) was performed is indicated in Table 1 . After the initial mixing and after every growth cycle, appropriate dilutions of the mixture were plated onto LB agar plates containing 40 mg/L X-gal and 100 mM (28.83 mg/L) IPTG. Plates were incubated overnight at 378C. Blue (lacZ +) and white (DlacZ) colonies were scored. The relative fitness (RF) was calculated as the ratio of the log 10 cfu densities of any strain harbouring some quinolone resistance mechanism and of E. coli ATCC 25922 DlacZ 6,25,26 [RF ¼ (log 10 S1 d1 -log 10 S1 d0 )/(log 10 S2 d1 -log 10 S2 d0 ), where S1 d1 and S1 d0 are the respective cfu densities of the mutant strain at the end and the beginning of the competition experiment, and S2 d1 and S2 d0 are the equivalent values for the control strain]. An RF score .1 indicated that the mutant strain had a selective advantage over the control strain, whereas a score ,1 represented a fitness cost. Note that fitness defects may be due to defects at any stage of the growth cycle (the lag, exponential or stationary phase).
ROS detection using 2
To determine whether there was a correlation between changes in the MIC or frequency of mutant associated with specific combinations of resistance mechanisms and ROS formation, we examined levels of radicals using the radical-sensitive fluorescent reporter dye DCHF-DA (SigmaAldrich). Microplate assays were performed using the Infinite 200Pro multimode microplate reader (Tecan). Flow cytometry was performed as previously described. 3 The excitation/emission wavelengths used were 485/530 nm. The average fluorescence was determined at 0 (baseline) and at 24 h for microplate assays, and at 0 and 4 h for flow cytometry (normalized to a no-dye control). Bacterial cells were treated with ciprofloxacin at a concentration of 1 mg/L. Ampicillin (10 mg/L) treatment was used as the control.
In vivo fitness in a mouse model of systemic infection
In vivo fitness was assessed by competition experiment using a mouse model of systemic infection. 27 For this, 1: 1 mixtures of each strain, grown overnight, were diluted to the required concentration and mixed at 5% (w/v) with porcine gastric mucin (Sigma-Aldrich). An aliquot of 500 mL of this mixture containing 4 log 10 cfu/mL of the final concentration was Machuca et al.
inoculated intraperitoneally into 10 female immunocompetent C57BL/6 mice weighing between 18 and 20 g. The mice were sacrificed with a lethal dose of sodium thiopental 24 h after inoculation and their spleens were aseptically extracted, weighed and processed for quantitative culture, after being homogenized in 2 mL of sterile saline solution (Stomacher 80; Tekmar Co., Cincinnati, OH, USA). After a 10-fold dilution, aliquots of 100 mL were plated on LB agar plates containing 40 mg/L X-gal and 100 mM IPTG. Plates were incubated at 378C overnight. Blue (lacZ +) and white (DlacZ) colonies were scored. When the cultures were negative, the spleen was considered to be sterile if there was no observable growth after plating all the homogenized tissue residue on LB agar plates containing X-gal and IPTG. The results were expressed as the mean+SD of the log 10 cfu/g in the spleen tissue. The numbers of cfu per strain and competition index values were determined, as described for in vitro competition experiments. During the experiments, mice were housed in regulation cages and given free access to food and water ad libitum. 
Real-time RT-PCR
To detect acrB gene expression (relative to the mdh gene), RT -PCR was carried out as previously reported, 28 using the 2 2DDCT method. The primers used are indicated in Table S1 .
Results
Effect of FQ resistance mechanisms on susceptibility to FQs
Sixty-one isogenic E. coli strains harbouring the most frequently found chromosomal mutations associated with FQ resistance in the gyrA and/or parC genes and/or a deletion in the marR gene were combined with qnr PMQR mechanisms and evaluated for susceptibility to quinolones (Table 1 and Table S2 ). The margin of error for the MIC values was +1 half-doubling step, so that any change of at least 2-fold was significant (experiments were performed in triplicate).
A single substitution in GyrA (S83L) increased the MICs 16-fold, and knockout mutations in marR just 2-fold. MICs obtained for double mutant combinations of chromosomal mechanisms were 16-to 64-fold higher than for the wild-type strain, with the DmarR combination showing the smallest increase. Certain combinations with parC and DmarR were not tested because parC mutations in E. coli are selected only after a prior mutation in gyrA. MICs for triple mutant combinations of chromosomal mechanisms were 32-to 250-fold higher than for the wild-type. MIC values for quadruple mutant combinations of chromosomal mechanisms were 500-fold higher than for the wild-type ( Table 1) .
The presence of any plasmid-mediated qnr gene increased the MIC levels in all E. coli genotypes. The ciprofloxacin MIC for E. coli ATCC 25922 harbouring any qnr gene was 0.03 -0.125 mg/L, which is 8-to 32-fold higher than for the empty wild-type strain (Table 1) with qnrC and qnrD1 conferring a lower resistance level. Combinations of only one chromosomal mechanism and qnr genes had MICs that were 4-to 32-fold and 32-to 128-fold higher than for the equivalent genetic background without the qnr gene and wild-type E. coli ATCC 25922, respectively. Combinations of two chromosomal mechanisms and qnr genes had MICs that were 2-to 16-fold and 64-to 1024-fold higher than for the equivalent genetic background without the qnr gene and wild-type E. coli ATCC 25922, respectively. MICs for combinations of triple chromosomal mechanisms and qnr genes were 2-to 16- 
In general, depending on the qnr gene, different levels of resistance were observed, with qnrS1 being the most effective resistance mechanism against FQs and qnrD1 the least effective. Similar levels of resistance were obtained against levofloxacin and moxifloxacin, with respect to ciprofloxacin; norfloxacin and ofloxacin were the least active FQs with the highest MICs (2-to 4-fold higher than the other FQs) (Table S2) .
One strain with two resistance mechanisms (EC24: S83L+qnrS1), several strains with three resistance mechanisms (8/18), most strains with four resistance mechanisms (13/16) and all strains with five resistance mechanisms had MICs that were equal to or above the 1 mg/L breakpoint defining clinical resistance in Europe, equivalent to 256-fold higher than the MIC for the wild-type in these strains. 29 In general, there was a direct correlation between the number of resistance mutations that a strain carried and the ciprofloxacin MIC (Table 1 and Figure 1a ).
Finally, we tested the contribution of two qnr genes that were present in the same strain. Using two compatible vectors, we analysed the effect on the resistance of qnrA1 and in combination with any other qnr gene (Table S3 ). The resultant MIC of these combinations of qnr genes was the same as that obtained by any qnr independently. Thus, no additive effect of two qnr mechanisms on the resistance was observed under these experimental conditions, in accordance with recent data. 30 
MPC of LLQR phenotypes
Seventeen isogenic strains harbouring between one and three resistance mechanisms (qnr and/or gyrA/parC modifications) were compared with wild-type E. coli ATCC 25922. MICs ranged between 0.03 mg/L and 4 mg/L, and most of the strains were susceptible to ciprofloxacin according to CLSI (15/17) or EUCAST (12/ 17) criteria (Figure 2 and Table S4 ). The MPC values of FQs for all isogenic strains with LLQR were higher than for the wild-type. The MPC values for strains with one, two and three resistance mechanisms were 2-to 8-fold (2 -8 mg/L), 8-to 32-fold (8 -32 mg/L) and 8-to 32-fold (8 -32 mg/L) higher, respectively, than for the wild-type strain (Table S4) . A similar increase was observed for levofloxacin.
Although the mutant selection window (MSW) was wider for wild-type E. coli ATCC 25922 (250) compared with the LLQR strains (8 -128), absolute MPC values in the LLQR strains were clearly higher than, and in most cases greatly exceeded, the breakpoint concentrations for resistance, following the CLSI and EUCAST criteria, and the serum C max for FQs. 19, 29, 31 The plates were incubated for up to 96 h, although in most cases 24 -48 h was sufficient for most strains to show colony growth, including visible colonies one dilution step below the MPC (Table S4) . 
Frequency of mutants in LLQR phenotypes
Nineteen isogenic E. coli strains harbouring one or two resistance mechanisms (qnr and/or gyrA modifications and/or marR deletion) were compared with wild-type E. coli ATCC 25922. The MICs were in the range 0.03 -1 mg/L; all of the strains were susceptible to ciprofloxacin according to CLSI criteria, and most of them (18/19) were susceptible according to EUCAST criteria (Table 2) .
To test the role of the LLQR phenotype in the emergence of clinical resistance levels, the selected strains were treated with either 4× MIC of ciprofloxacin or 1 mg/L ciprofloxacin. At a fixed concentration of 1 mg/L ciprofloxacin, a significant increase in the rate of mutants was observed in strains containing an S83L modification or marR deletion in combination with any qnr gene (up to 10 1 -10 4 -fold) ( Tables 1 and 2 ). Specifically, combinations of S83L and qnrA1 or qnrS1 increased the mutant rate by 10 3 -and 10 4 -fold, respectively, relative to the wild-type. Minor differences in the rate of mutants were observed when 4× MIC of ciprofloxacin was used (Tables 1 and 2 ). In order to verify the possible impact of these mechanisms on cross-resistance, assays were also performed with 100 mg/L rifampicin, although no differences between the strains were observed (data not shown). In some cases, more than one symbol occupies the same space. Strain identification numbers are shown for six strains of particular interest (see Table 3 ).
Twenty-eight stable derived mutants were selected for molecular characterization. Only two of them showed additional modifications in the quinolone resistance-determining region (S83L modification). Unexpectedly, most mutants (70%) expressed between 3-and 35-fold (n¼ 20) more acrB, compared with each genetic background used for the assay ( Figure S1 ). acrB overexpression was even observed in strains with a previous marR deletion, indicating that other regulatory genes were affected.
Clinical resistance to ciprofloxacin following EUCAST criteria 29 (MIC of ciprofloxacin .1 mg/L) was observed for 35% of mutants derived from isogenic strains containing the S83L modification or marR deletion in combination with the qnr gene (data not shown).
No one-step clinically resistant mutants were obtained from wildtype E. coli ATCC 25922 or derived isogenic strains containing a modification at S83L, marR deletion or one qnr gene as the single resistance mechanism.
ROS production in isogenic strains containing quinolone resistance mechanisms
We found a highly significant correlation (R 2 ¼ 0.98) between changes in MIC/mutant rates and the peak DCHF-DA signal (Figure 3 ). The production of ROS decreased in proportion to the number of modifications. One modification decreased ROS production by 20% -40%, two modifications by 55% -65%, three modifications by 70% -80% and four modifications by about 90% (Figure 3a) . Plasmid-mediated qnr mechanisms decreased the production of ROS alone (by about 50%) and in combination with a marR deletion or S83L substitution (by about 50% -60% and 60% -70%, respectively), relative to the wild-type strain 
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Interplay between fluoroquinolone resistance and bacterial fitness 3209 JAC (Figure 3a and b) . Plasmid-mediated qnr mechanisms also decreased ROS production relative to a marR deletion or an S83L substitution (by about 40% -60% and 10% -45%, respectively) (Figure 3c and d) . These results were validated by cytometry assays ( Figure S2 ). No differences were observed when ampicillin (10 mg/L) was assayed, indicating that the observed differences were related to specific molecular mechanisms of quinolone resistance (and derived higher MICs; data not shown). This strong correlation between a decrease in ROS and changes in MIC/ mutant rates after treatment with bactericidal antibiotics (1 mg/L ciprofloxacin) suggests that ROS may actively contribute to bactericidal drug-induced mutagenesis.
In vitro growth curves
A growth curve experiment was performed to assess growth rates under non-competitive conditions and so check the effect on the growth rate of E. coli of carrying chromosomal and PMQR mechanisms. No marked differences, in terms of maximal growth rate or doubling time, were observed during the exponential phase. In addition, we analysed the effect of qnr genes on growth capacity in LB and M9 media. The patterns of the curves were similar for all strains ( Figure S3A ) in LB medium, although a delay was observed at the start of the exponential phase for strains containing qnr genes in poor M9 medium ( Figure S3B ). There was no delay when assays were repeated in the presence of 0.5× MIC of ciprofloxacin, reflecting the selective advantage of possessing a qnr gene in the presence of FQs under these experimental conditions ( Figure S3C ).
In vitro bacterial fitness of resistant isogenic strains
The 59 mutant strains were tested in growth competitions against the wild-type to measure Malthusian fitness in relation to the resistance mutations carried (Table 1) . In E. coli ATCC 25922, the fitness value associated with chromosomal mechanisms (one to four resistance mutations) was not associated with reduced fitness, and for some combinations (DmarR, 1.08; S83L + S80R, 1.20; S83L + S80R + DmarR, 1.07; and S83L + D87N, 1.14) significantly increased fitness was observed. Interestingly, although increased fitness was observed for DmarR alone, reduced fitness (2%-17%) was also observed when this deletion was combined with any other chromosomal mutations (Table 1) .
In an antibiotic-free environment, bacterial strains carrying plasmids harbouring resistance genes compete with strains that do not possess such resistance genes. The presence of plasmids encoding for Qnr proteins modified bacterial fitness depending on the combination of chromosomal mutations (Table 1, Figure 4 and Figure S4 ). The pattern was variable in the case of qnrB1 or qnrC combinations. qnrA1, qnrB1 and qnrC did not modify bacterial fitness on their own, whereas qnrD1 and qnrS1 alone increased bacterial fitness (1.09 and 1.14, respectively). In general, qnrA1 had a higher fitness cost in combination with chromosomal mutations, whereas qnrD1 and qnrS1 conferred increased fitness. A significant fitness cost (P, 0.05) was observed when qnrA1 was combined with DmarR, S83L+DmarR, S83L+ S80R + DmarR, S83L + D87N and S83L + D87N +S80R (from 7% to 21%). On the other hand, when qnrS1 was combined with DmarR, S83L, S83L +D87N + DmarR and S83L+ D87N+ S80R, there was a significant increase in fitness (P,0.05) (from 9% to 21%) (Figure 4) . Table 1 ). Statistically significant differences (P,0.05) relative to the control are indicated by an asterisk.
Strains carrying one or two resistance mechanisms had fitness values that ranged between 0.92 and 1.21, with 1/20 strains having a fitness value significantly lower than 1 (DmarR+qnrA1). Adding a third and fourth resistance mechanism to these strains produced a variable fitness pattern, with a minimum fitness value of 0.79 per generation (S83L+ DmarR+qnrA1) and a maximum fitness value of 1.16 (S83L + D87N + DmarR +qnrS1) (Figure 1b) . When all five resistance mechanisms were present, the fitness value was ≤1 (0.86 and 0.87 for EC56 and EC59, respectively). Thus, fitness did not decrease as a simple function of the number of resistance mutations but rather depended critically on the nature of the mutations.
Susceptibility and in vitro fitness correlation
In general, the addition of a resistance mechanism to a strain increased the MIC and had a variable effect on fitness cost. The MICs for EC54 and EC55 strains were comparable to clinical resistant isolates (MIC 4 -8 mg/L), with increased fitness and a non-significant reduction in fitness, respectively, relative to the wild-type (Figure 4 ). These strains show that it is possible to evolve high-level resistance without a fitness cost in combinations of chromosomal-and plasmid-mediated mechanisms. Some specific combinations caused an increased MIC and increased fitness (Tables 1 and 3) . A comparison of EC28 and EC38 showed that the presence of S80R in ParC increased the MIC of ciprofloxacin from 0.5 to 2 mg/L, with a 10% increase in bacterial fitness also observed at the same time. A similar effect was observed when EC44 and EC49 were compared in the presence of an additional marR deletion. On the other hand, other specific combinations gave an increased MIC and decreased fitness (Tables 1 and 3) . A comparison of EC30 and EC35 showed that the presence of the marR deletion increased the MIC of ciprofloxacin from 2 to 8 mg/L E C 1 9 E C 2 4 E C 2 9 E C 3 4 E C 3 9 E C 4 4 E C 4 9 E C 5 4 E C 5 9 Interplay between fluoroquinolone resistance and bacterial fitness 3211 JAC and at the same time reduced bacterial fitness by 9%. Modified fitness was statistically significant (Student's t-test, two-tailed, P,0.05) in these three cases (Table 3) . Thus, adding a single resistance mechanism can modify growth fitness by 10% per generation and simultaneously increase the MIC from susceptibility to resistant values, according to clinical breakpoints (Table 3) .
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In vivo bacterial fitness in a mouse infection model
The data in the previous sections showed that specific combinations of chromosomally and/or plasmid-mediated mechanisms could significantly increase or reduce competitive growth fitness measured in vitro. This result would be more interesting from a clinical viewpoint if the increased fitness measured were not exclusively an in vitro phenomenon. To test this, competition experiments were carried out on a mouse model of systemic infection. 27 Each of the strains (EC25, EC31 and EC50 with reduced in vitro fitness, and EC14, EC19 and EC24 with enhanced in vitro fitness) competed against the isogenic wild-type in the mouse model and the RF was expressed in terms of a competition index. For these six selected strains (and the E. coli ATCC 25922 wild-type control included), there was a clear positive correlation between RF in vivo and in vitro ( Figure 5) . Thus, the relative order of the fitness values for strains initially measured in vitro was confirmed in a physiologically more complex in vivo environment.
Discussion
Understanding the basis of fitness costs in bacteria carrying chromosomal and PMQR mechanisms is clinically relevant since quinolones are frequently used in the treatment of bacterial infections and qnr genes are becoming more prevalent in GNB, particularly Enterobacteriaceae. 4, 9 A thorough understanding of the resistance development process is needed to facilitate the rational design of countermeasure strategies. This topic is difficult to address because genetic factors are so diverse, which may influence the final outcome. For this reason, the experiments presented here were performed with a set of 61 isogenic E. coli strains, constructed and analysed under identical conditions, so that the results measured precisely the relationship between the accumulation of FQ resistance mechanisms, drug susceptibility, mutant rate and bacterial fitness.
The main question was whether the accumulation of resistance mechanisms commonly found in resistant clinical isolates progressively modified bacterial fitness, then determining combinations of mechanisms that led to significant clinical resistance. The relationship between drug resistance and bacterial fitness is complex and we found: (i) combinations causing little or no fitness cost; (ii) combinations causing a progressive decrease in bacterial fitness; and, interestingly, (iii) some combinations of resistance mechanisms where there was a positive relationship between reduced drug susceptibility and increased bacterial fitness. Thus, the combinations of a mutation S83L in GyrA plus S80R in ParC, and S83L plus D87N in GyrA, enhanced bacterial fitness relative to wild-type E. coli ATCC 25922 or mutants containing only the S83L modification. These data could indicate that some common mutations associated with resistance modify bacterial fitness and that this may be dependent on the genetic background investigated. 6, 32 With respect to the qnr genes, most of the combinations harbouring qnrA1 had a significant fitness cost, while most of the combinations harbouring qnrS1 had a significantly enhanced bacterial fitness (Table 1 and Figure 4 ). These positive relationships could represent an additional driving force in the development of increased resistance to quinolones. The data for plasmid-mediated mechanisms support a similar previously reported phenomenon for chromosomally mediated resistance in bacteria. 6 In a model derived from E. coli K12, Marcusson et al. 6 showed that although the first quinolone resistance mutations (mostly gyrA) had fitness costs, later compensatory parC mutations were able to confer increases in both resistance and fitness, suggesting that a higher level of resistance could be selected in the absence of antimicrobial exposure. Michon et al. 25 reported that the qnrA3 allele enhanced bacterial fitness in wild-type E. coli; in that study, the interplay between other resistance mechanisms was not analysed. On the other hand, we did not focus on the impact of natural plasmids harbouring qnr genes in this study because it would have been difficult to interpret the effect when qnr genes were included in complex structures.
The observations described here and in the literature may have broad biological significance. Particular combinations of resistance mechanisms may potentially be selected because they reduce drug susceptibility and/or because they improve the RF of the mutant strain. 6, 15, 33 For example, in the absence of antimicrobial pressure, the presence of certain qnr genes, particularly qnrS1, could lead to the selection of additional resistance mechanisms with enhanced bacterial fitness. Similar examples of fitness benefits in FQ resistance in the absence of antimicrobial pressure were recently reported in Salmonella and Campylobacter genuses. 32, 34, 35 The results obtained in the experimental animal model corroborated those obtained in the in vitro fitness assays.
The particular gyrA and parC resistance mutations studied here are clinically relevant and are among those most commonly found among the FQ-resistant clinical isolates of E. coli. 16, 18, 36 The combination of target mutations and plasmid-mediated mechanisms in this study is found in resistant clinical isolates. Although the marR deletion has been described as producing a fitness cost, 6 a variable effect that could be strain-dependent was observed in E. coli ATCC 25922, depending on the combination of mechanisms. Furthermore, we observed that a significant percentage of derived mutants overexpressed acrAB ( Figure S1 ) and led to high-level resistance. It has also recently been suggested that acrAB overexpression, whether or not it is dependent on marR, plays an important role in the temporal interplay of quinolone resistance in E. coli. 37 According to our data, the low rate of selection of topoisomerase mutants from strains of E. coli harbouring plasmid-borne qnr genes has previously been reported. 38 Mutations up-regulating drug efflux are highly relevant to the evolution of resistance because they arise at a rate hundreds of times higher than mutations in the structural genes for the topoisomerases. So, even though, as shown here, efflux mutations make a relatively small contribution to increased resistance, they occur very frequently and are found in many resistant clinical isolates. 39 The epidemiological cut-off for ciprofloxacin in E. coli was established at 0.032 mg/L (www.eucast.org), which correlates with strains without quinolone resistance mechanisms, which means the wild-type population. The definition of wild-type strains is difficult to make due to the possible expression of unknown LLQR. 40, 41 Here we add evidence of the existence of strains (highly susceptible laboratory strains) with LLQR mechanisms and MICs equal to or less than the epidemiological cut-off (EC01 and EC13; Table 1 ). Our data show that at least three modifications to the target of quinolone action, or a combination of S83L substitution, marR inactivation and qnr expression, were necessary to produce a clinical (EUCAST breakpoints) resistance phenotype (MIC of ciprofloxacin .1 mg/L). In accordance with these data, we should allow for the possibility that additional LLQR mechanisms could be contributing to quinolone resistance in clinical isolates to obtain the high level of resistance.
Our data showed that changes in MIC/mutant rates correlated with ROS formation. ROS production decreased in proportion to the number of modifications (Figure 3) . The strong correlation between a decrease in ROS and changes in MIC/mutant rates following treatment with bactericidal antibiotics suggests that ROS may actively contribute to bactericidal activity in fully susceptible strains and to drug-induced mutagenesis in LLQR strains, depending on the level of ROS production. 3, 42 Qnr proteins bind to type II topoisomerases even without quinolone binding to their targets. 43, 44 Although it seems that Qnr proteins do not usually interfere with the in vitro activity of E. coli gyrase at concentrations at which they prevent FQ inhibition, 4, 44, 45 other Qnr-like proteins inhibit the catalytic activity of topoisomerases in their natural host. 45, 46 Crystallographic data on the structure of Qnr-like PRPs, such as MfpA, EfsQnr and AhQnr, 47 -49 revealed a right-handed b-helix structure that mimics the double helical structure of DNA. Mimicking the structure of DNA might have consequences for the cell cycle and replication. It is also unknown whether GyrA and ParC modifications affect the binding of Qnr and modify the activity of type II topoisomerases or other related proteins. In summary, these data may Interplay between fluoroquinolone resistance and bacterial fitness 3213 JAC explain the impact on fitness and may be specific to the amino acid sequences of the different Qnr proteins. In this respect, the differential epigenetic compatibility of qnr genes with the chromosome of E. coli has been reported. 50 To our knowledge, no clear explanation has been given as to why some qnr genes are often isolated from a specific genus whereas others are scarcely detected at all in specific microorganisms. Identifying the different impacts of different qnr genes expressed in members of the Enterobacteriaceae may contribute to our understanding of why some are more widespread in some GNB than in others. While most qnr genes have been found in Enterobacteriaceae, practically none has been reported in Pseudomonas aeruginosa or Acinetobacter spp. 4, 51 qnrB is frequently associated with Klebsiella pneumoniae and Klebsiella spp., and despite the fact that qnrA was the first qnr gene described, 52 its prevalence in E. coli is low, while qnrS is usually found with greater prevalence. 4, 9, 53, 54 Our data provide an insight into the likely initial effects of different pathways of resistance development on RF and drug susceptibility. How FQ resistance (chromosomal-and plasmid-mediated) evolves in nature will depend on the genotype selected and the selective environment, 55 although there may be critical stages in its resistance development, which means that some low-fitness mutants below the resistance breakpoint that are difficult to detect in a clinical setting may evolve to clinical resistance in just one or two mutations with increased fitness and without additional exposure to the drug.
